Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.180
+0.170 (4.24%)
May 1, 2026, 4:00 PM EDT - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Research and Development of Diagnostic Tests for The Detection of Cancer | 4.05M | 1.88M | 1.50M | 958.00K | 2.20M | | | | | |
Research and Development of Diagnostic Tests for The Detection of Cancer Growth | 115.58% | 25.15% | 56.89% | -56.41% | 80.76% | | | | | |
| 4.05M | 1.88M | 1.50M | 958.00K | 2.20M | | | | | |
| 115.58% | 25.15% | 56.89% | -56.41% | 80.76% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 4.03M | 1.67M | 916.83K | 737.66K | 1.00M | | | | | |
| 140.94% | 82.48% | 24.29% | -26.57% | 35.42% | | | | | |
| 24.00K | 18.00K | - | - | - | | | | | |
| 33.33% | - | - | - | - | | | | | |
| - | 45.00K | - | - | - | | | | | |
| - | 145.00K | - | - | - | | | | | |
Outside of The United States | - | - | 586.17K | 220.34K | 1.24M | | | | | |
Outside of The United States Growth | - | - | 166.03% | -82.18% | 160.70% | | | | | |
| 4.05M | 1.88M | 1.50M | 958.00K | 2.24M | | | | | |
| 115.58% | 25.15% | 56.89% | -57.25% | 84.28% | | | | | |
Source: S&P Global Market Intelligence.
